EQT Partners has increased its offer from SEK 5.973bn (€575m) to SEK 6.151bn (€602m) for the take-private of Stockholm-based pharmaceutical company Karo Pharma.
BEX III should hold a first and final close by Q2 2019 near its $350m hard-cap
VCs including Signals Venture Capital and Idinvest Partners invest in the scooters business
Previous backer Sofinnova Partners and new investor Sectoral Asset Management also take part
Altor took credit management firm Transcom private at an enterprise value of €240m